ZAMO', Alberto
 Distribuzione geografica
Continente #
NA - Nord America 5.186
EU - Europa 4.510
AS - Asia 2.093
SA - Sud America 26
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 4
Totale 11.838
Nazione #
US - Stati Uniti d'America 5.151
GB - Regno Unito 1.613
CN - Cina 1.332
SG - Singapore 568
IT - Italia 500
SE - Svezia 433
FR - Francia 417
RU - Federazione Russa 357
FI - Finlandia 323
DE - Germania 309
IE - Irlanda 279
UA - Ucraina 126
BE - Belgio 60
TR - Turchia 42
CA - Canada 30
NL - Olanda 30
VN - Vietnam 25
IN - India 21
IR - Iran 20
KR - Corea 18
JP - Giappone 17
AU - Australia 12
ES - Italia 11
BR - Brasile 10
IL - Israele 10
ID - Indonesia 9
CL - Cile 7
RO - Romania 7
CH - Svizzera 6
NP - Nepal 5
A2 - ???statistics.table.value.countryCode.A2??? 4
LT - Lituania 4
AL - Albania 3
AR - Argentina 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
EE - Estonia 3
EU - Europa 3
HU - Ungheria 3
LU - Lussemburgo 3
LV - Lettonia 3
MX - Messico 3
MY - Malesia 3
PK - Pakistan 3
PY - Paraguay 3
AZ - Azerbaigian 2
BY - Bielorussia 2
EG - Egitto 2
HK - Hong Kong 2
IQ - Iraq 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
CO - Colombia 1
CY - Cipro 1
EC - Ecuador 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
PL - Polonia 1
RS - Serbia 1
SI - Slovenia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 11.838
Città #
Southend 1.480
Jacksonville 990
Chandler 824
Woodbridge 524
Singapore 478
Ann Arbor 466
Dublin 279
Ashburn 272
Houston 263
Beijing 242
Wilmington 157
Lawrence 143
Princeton 143
Jinan 120
Nanjing 118
Verona 96
New York 95
Shenyang 91
Hebei 70
Helsinki 69
Sindelfingen 67
Brussels 60
Boardman 56
Ningbo 55
Tianjin 55
Nanchang 54
Haikou 41
Zhengzhou 37
Changsha 36
Milan 36
Jiaxing 33
Taizhou 33
Dearborn 32
Hangzhou 31
Bologna 26
Guangzhou 26
Taiyuan 26
Fairfield 24
Los Angeles 24
Norwalk 23
Redmond 21
Lancaster 20
Groningen 19
Falls Church 18
Rome 17
Seoul 17
Fuzhou 15
Redwood City 13
Santa Clara 13
San Francisco 12
Toronto 12
Chicago 11
Dallas 11
Dongguan 11
Düsseldorf 11
Kent 11
Leawood 11
Seattle 11
Dong Ket 10
Lanzhou 10
Tokyo 10
Washington 10
Zanjan 10
Clearwater 9
Moscow 9
Wuhan 9
Jakarta 8
Paris 8
Torino 8
Augusta 7
Cambridge 7
Catania 7
Châtenay-Malabry 6
Frankfurt am Main 6
Palermo 6
Qingdao 6
San Mateo 6
Amsterdam 5
Asiago 5
Auburn Hills 5
Hyderabad 5
Madrid 5
Parsa 5
San Diego 5
Verdun 5
Andover 4
Denver 4
Hefei 4
Irving 4
London 4
Munich 4
Newark 4
Ottawa 4
Riva 4
Romola 4
San Jose 4
Shenzhen 4
Trieste 4
Ardabil 3
Buenos Aires 3
Totale 8.199
Nome #
Leucemia linfatica cronica/linfoma linfocitico (LLC): l'espressione di ZAP-70, analizzata alla diagnosi su biopsia ossea, è un importante fattore prognostico 264
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 228
Espressione di TP73L nei linfomi B a grandi cellule primitivi del mediastino: un utile marcatore diagnostico 152
Chromium-induced diffuse dermatitis with lymph node involvement resulting from Langerhans cell histiocytosis after metal-on-metal hip resurfacing 149
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 149
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 141
Espressione di marcatori di migrazione e invasività nei foci fibroblastici nella fibrosi polmonare idiopatica 139
B-cell chronic lymphocytic leukemia cells espress functional death receptor 3 following stimulation of the B cell receptor 137
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 135
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 133
Detection of allele-specific gene expression on next generation sequencing data 128
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 125
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 123
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 123
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 121
Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma. 120
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells 119
CD10 is expressed in a subset of chromophobe renal cell carcinomas 117
slan+ monocytes and macrophages mediate CD20-dependent B cell lymphoma elimination via ADCC and ADCP 116
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 114
Establishment of the MAVER -1 cell line, a model for leukemic and aggressive mantle cell lymphoma. 114
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 113
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 111
Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypy 109
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 109
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 108
ALK-positive anaplastic large cell lymphoma with PAX-5 expression: report of a case 107
Analysis of colorectal cancers for human cytomegalovirus presence 105
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis 104
Application of a commercial software to the analysis of infrared structural images on lymph node tissues: a preliminary study 104
The role of disease causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. 101
Microfluidic Deletion/Insertion Analysis for Rapid Screening of KIT and PDGFRA Mutations in CD117-Positive Gastrointestinal Stromal Tumors: Diagnostic Applications and Report of a New KIT Mutation. 99
Induction of apoptosis in Jeko-1 mantle cell lymphoma cell line by resveratrol: a proteomic analysis. 98
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis 98
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma. 97
FPA micro spectral imaging of non-Hodgkin lymphomas 96
In Vitro and In Vivo Model of EBV-Positive Non-Hodgkin Plasmablastic Lymphoma with Focal Plasmacytic Differentiation 95
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 95
Use of a Chip-based microfluidic apparatus in the analytic step of the Biomed-2 protocol for the detection of B-cell clonality 94
GREY ZONES OF HODGKIN LYMPHOMA: REPORT OF A CASE WITH FEATURES INTERMEDIATE BETWEEN PRIMARY MEDIASTINAL B-CELL LYMPHOMA, CLASSICAL HODGKIN LYMPHOMA AND NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA 94
Short-term, intensive chemotherapy regimen is equally effective in Burkitt lymphoma (BL) and in the novel WHO 2008 entity “B-cell lymphoma intermediate between DLBCL and BL". 94
A 6-GENE EXPRESSION SIGNATURE IN MANTLE CELL LYMPHOMA: RESULTS FROM THE FONDAZIONE ITALIANA LINFOMI (FIL)-MCL-0208 TRIAL 94
Evaluation of S-phase fraction as a prognostic marker in mantle cell lymphoma 92
Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours 91
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 91
Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis 90
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 89
Tissue proteomics of splenic marginal zone lymphoma 89
Haploidentical hematopoietic stem cell transplantation in a myelofibrosis patient with primary graft failure 89
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis 88
Identification of the core phosphoproteome of mantle cell lymphoma cell lines 88
An unusual case of sarcoidosis in an adult patient with sickle cell disease: Management with methotrexate and low dose of steroid 88
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 88
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis 87
Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. 87
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 87
VR09 Cell Line: An EBV-Positive Lymphoblastoid Cell Line with In Vivo Characteristics of Diffuse Large B Cell Lymphoma of Activated B-Cell Type 87
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death 86
Application of Microfluidic Technology to the BIOMED-2 Protocol for Detection of B-Cell Clonality 86
Signal transduction pathways of mantle cell lymphoma: a phosphoproteome-based study. 86
Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas 85
In reply to Schäfer et al: new evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma 85
A Rare Disorder in an Orphan Disease: Kikuchi Fujimoto Disease in a Young-Adult Patient with Sickle Cell Anemia 85
Resveratrol activity on MCL cell line jeko-1: a proteomic approach 84
Utilizzo di un apparato microfluidico per il rilevamento del riarrangiamento clonale dei geni delleimmunoglobuline secondo il protocollo BIOMED-2 83
PHOSPHOSCAN ANALYSIS OF MANTLE CELL LYMPHOMA CELL LINES 83
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways 83
[Primary large B cell non-Hodgkin's lymphoma of the mediastinum] 83
Utilizzo dell'analisi microfluidica per il rilevamento di mutazioni dei geni KIT e PDGFRA nei tumori dello stroma gastroenterico. 82
CD16 expression in T-cell lymphomas: analysis on paraffin embedded tissues using the 2H7 antibody. 82
Phosphoproteome profiling of mantle cell lymphoma cell lines 82
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathwayn as a potential therapeutic target 82
Activated KIT hyperexpression in thymic carcinoma: a potential target for therapeutic intervention. 80
Metodi e tecniche dell'anatomia patologica 80
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathway as a potential therapeutic target. 80
Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas 79
Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua 79
Anaplastic large-cell lymphoma 78
Induction of apoptosis in Jeko-1 mantle cell lymphoma cell line by resveratrol : a proteomic analysis 77
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 76
Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer. 73
Stat3 and Ras activation are required for the cellular transformation mediated by NPM-ALK 72
Models for quantitative individual grading and prognosis in breast malignancies 72
Quantitative evaluation of differential expression of p63 isoforms in primary mediastinal B-cell lymphomas by real-time PCR 72
Application of a commercial software to the analysis of infrared spectral images on lymph node tissues: a preliminary study. 72
TCL1A expression in marginal zone lymphoma: a clinico-pathological evaluation in paired spleen and bone marrow samples 71
Modified HyperCVAD and rituximab for the treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. 71
ALK-mediated activation of STAT3 elicits growth and anti-apoptotic signals. 70
Identification of a three-gene model as a powerful diagnostic tool for the recognition of ALK negative ALCL 69
Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12. 69
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. 67
Expression of c-kit and activated c-kit (phospho c-kit) in thymic carcinomas and WHO type B3 thymomas 67
Anaplastic lymphoma kinase in human cancer 67
Impacts: planning a European initiative for standardized protein analysis of archival clinical tissues 67
VDJSeq-Solver: In Silico V(D)J Recombination Detection Tool 67
Proteomic characterization of two mantle cell lymphoma cell lines 66
The mantle cell lymphoma website: a free web-based resource for mantle cell lymphoma researchers 66
The Who Classification of Lymphomas of the Mediastinum: Pathology and Genetics 65
p53-p63 cross-talk in lymphomas 65
Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis 65
Totale 9.662
Categoria #
all - tutte 40.762
article - articoli 22.161
book - libri 0
conference - conferenze 17.927
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 674
Totale 81.524


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020747 0 0 0 0 0 0 141 131 59 145 86 185
2020/20211.310 96 230 65 147 162 140 17 95 89 20 202 47
2021/20221.198 99 398 5 96 44 28 13 76 47 41 105 246
2022/20232.380 174 241 248 438 223 523 16 141 275 20 53 28
2023/20241.095 59 102 78 145 132 178 42 74 15 48 146 76
2024/20251.157 135 230 87 474 122 78 31 0 0 0 0 0
Totale 11.962